Recent government pricing reviews revealed that distributor mark-ups on key anti-cancer therapies surged up to 700% despite receiving price caps back in 2019. In response, regulators imposed a 30% trade margin ceiling on 137 non-scheduled cancer medicines to enforce retail price drops of up to 70% beginning November 9. However, advocacy groups warn that these periodic adjustments do not permanently fix systemic pricing loopholes. Furthermore, an analysis indicated that 159 of the 643 reviewed drug packs received zero price reductions, leaving many costly patented therapies completely unaffected.
Key points
Periodic price interventions allow distributor mark-ups to escalate again unless authorit…: Periodic price interventions allow distributor mark-ups to escalate again unless authorities establish continuous trade margin oversight.
The overall pricing exercise yielded an average price drop of 38.22 percent across the mo…: The overall pricing exercise yielded an average price drop of 38.22 percent across the monitored anti-cancer drug list.
Nearly a quarter of analyzed drug packs experienced no price decline, leaving several exp…: Nearly a quarter of analyzed drug packs experienced no price decline, leaving several expensive patented treatments untouched.
Sources checked by our analysis pipeline: 1
An analysis of drugs covered by the earlier exercise shows that mark-ups on a majority of the medicines had climbed to 100%-700% by 2026, prompting patient groups to question whether one-time reductions in maximum retail prices (MRPs) can keep medicines affordable.
Also Read: NPPA list brings little relief: No price cut for 25% cancer drugs
The All-India Drug Action Network (AIDAN), which works on access to affordable medicines, has flagged the trend, arguing that restricting MRPs without a continuing mechanism to control trade margins could allow the same problem to resurface.
According to a report by The Times of India (TOI), 34 of the 137 anti-cancer drugs included in the National Pharmaceutical Pricing Authority's (NPPA) latest list featured in the regulator's 2019 list of 42 cancer drugs. An analysis of the overlapping medicines showed that most had mark-ups above the level equivalent to the 30% trade margin cap introduced in 2019.
Only five brands from the earlier list had mark-ups of 43% before the latest price revision, while another four had mark-ups between 43% and 100%. The mark-ups on most…
Emergency medical teams in Anantapur mobilized to treat two young female victims following a violent classroom intrusion in Andhra Pradesh. The assailant bypassed school grounds armed with a powered cutting tool to target the students during active instruction. Both individuals required immediate hospital admission to address the injuries sustained during the sudden assault.
Law enforcement launched an active manhunt northeast of San Francisco following a sudden outbreak of retail violence on Friday night. The gunfire struck multiple victims inside a busy seasonal shop just as community members prepared for holiday celebrations. Investigators are actively pursuing leads to determine who carried out the deadly attack.
First identified four decades ago, this cyclical condition impacts millions across the Northern Hemisphere by disrupting biological clocks and mental well-being during darker months. Women face an elevated risk of developing these debilitating seasonal symptoms, which persist for roughly forty percent of the year. Establishing early interventions through targeted light exposure helps counter severe lethargy and behavioral shifts before they worsen.